| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Imperial Cancer Research Fund Oncology Group, Royal Postgraduate Medical School, Hammersmith Hospital, London W120HS, England
Indium-111-labeled AUA1 tumor-associated monoclonal antibody raised against an antigen of colon adenocarcinoma was used to evaluate the effect of ionizing radiation on antibody uptake by the LoVo adenocarcinoma cell line grown as a xenograft in nude mice. Tumors were exposed to single doses of external X-irradiation of between 400 and 1600 cGy followed, 24 h later, by administration of specific or nonspecific antibody. Animals were sacrificed 3 days after antibody administration. At doses higher than 400 cGy, tumor uptake with both specific and nonspecific antibody was significantly increased. No difference in changes in tumor volume was observed between the groups receiving irradiation and the controls. Specific antibody uptake by tumors was always significantly higher than nonspecific having an approximate 4-fold binding advantage. Vascular permeability and the vascular volume of irradiated and control tumors was measured 24 and 72 h after irradiation, using iodine-125-labeled nonspecific antibody and labelling of the red blood cells in vivo with 99mTcO4. At doses higher than 400 cGy, vascular permeability in the tumor 24 h after irradiation was significantly increased (P < 0.05), while the vascular volume decreased (P < 0.001) compared to control values. However at 72 h after irradiation there was no difference between treated and control groups.
The results obtained in this study suggest a potential value of external irradiation to increase monoclonal antibody uptake by tumors governed mainly by the increased vascular permeability of the tumor vasculature soon after the irradiation exposure.
1 This work was supported by the Imperial Cancer Research Fund.
2 To whom requests for reprints should be addressed, at ICRF Oncology Group, Hammersmith Hospital, DuCane Road, London W120HS, England.
Received 3/20/89. Revised 7/31/89. Accepted 10/ 2/89.
This article has been cited by other articles:
|
|
 |
|
  R. Hassan, J. Williams-Gould, S. M. Steinberg, D. J. Liewehr, J. Yokokawa, K. Y. Tsang, R. J. Surawski, T. Scott, and K. Camphausen Tumor-Directed Radiation and the Immunotoxin SS1P in the Treatment of Mesothelin-Expressing Tumor Xenografts. Clin. Cancer Res., August 15, 2006; 12(16): 4983 - 4988. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. d. L. Davies, L. M. Lundstrom, J. Frengen, L. Eikenes, O. S. Bruland, O. Kaalhus, M. H. B. Hjelstuen, and C. Brekken Radiation Improves the Distribution and Uptake of Liposomal Doxorubicin (Caelyx) in Human Osteosarcoma Xenografts Cancer Res., January 15, 2004; 64(2): 547 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Znati, M. Rosenstein, T. D. McKee, E. Brown, D. Turner, W. D. Bloomer, S. Watkins, R. K. Jain, and Y. Boucher Irradiation Reduces Interstitial Fluid Transport and Increases the Collagen Content in Tumors Clin. Cancer Res., November 15, 2003; 9(15): 5508 - 5513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kurizaki, S. Okazaki, S. D. Sanderson, D. Colcher, C. A. Enke, M. A. Tempero, and J. Baranowska-Kortylewicz Potentiation of Radioimmunotherapy with Response-Selective Peptide Agonist of Human C5a J. Nucl. Med., July 1, 2002; 43(7): 957 - 967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ruan, J. A. O'Donoghue, S. M. Larson, R. D. Finn, A. Jungbluth, S. Welt, and J. L. Humm Optimizing the Sequence of Combination Therapy with Radiolabeled Antibodies and Fractionated External Beam J. Nucl. Med., November 1, 2000; 41(11): 1905 - 1912. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
